biotech

At MIDI, taking the cutting edge on the road

By GREGORY ZELLER // Nearly a year after giving itself a massive home-field advantage, MIDI Medical Product Development is putting in some roadwork. Last week, it was Medical Device & Manufacturing West, a California showcase that annually attracts more than 20,000 medtech engineers and executives – a virtual mothership to the Smithtown-based medical maker. In May, it will be BIOMEDevice, an MD&M event in Boston promoted as “New England’s largest medtech event,” then MD&M East…


Novel Parkinson’s Procedure Pumps Up NSUH

By GREGORY ZELLER // They’re dancing in the aisles, literally, at North Shore University Hospital, thanks to a revolutionary treatment for Parkinson’s disease. Surgeons at the Manhasset hospital, part of the Northwell Health system, recently completed their first endoscopic procedure involving Duopa, an effective drug combo administered via a cutting-edge cassette-pump system marketed by Chicago-based pharma AbbVie Inc. Approved by the FDA in January, Duopa marks the first Parkinson’s disease treatment to administer medicine –…


Applied DNA Taking it to Swedish car thieves

By GREGORY ZELLER // Let this be a warning to Swedish car thieves: Applied DNA Sciences is on the case. Through Safesolutions AB (bring your Swedish or try the Google Translate version), the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft, product-genotyping and product-authentication specialist is now applying its flagship SigNature DNA products to luxury cars imported into Sweden. Safesolutions, Applied DNA Sciences’ Swedish distributor, has inked a contract with Swedish importers that will mark a minimum of…


Pharm hand: Why Rechler Equity is big on biotech

By GREGORY ZELLER // Anyone still doubting the importance of the pharmaceutical and biotech industries to the Long Island economy should take a peek at Rechler Equity Partners’ portfolio. This branch of the royal family of LI real estate didn’t set out to anchor its commercial holdings with biotech tenants, but over the last decade-plus, “it happened organically,” noted Mitchell Rechler, who co-manages the Plainview-based real estate giant – and its 6 million square feet…


Tech plays center stage in latest funding contest

With visions of a thriving innovation economy front and center, Long Island business and academic leaders are shooting for $105 million in commercialization funds through the annual Regional Economic Development Council competition. The Long Island council, comprised of more than 20 businesspeople and academicians appointed by Gov. Andrew Cuomo, pored over 254 applications from Nassau and Suffolk companies, governments and nonprofits – the highest number of applications since the contest launched on 2011 – to determine…


DEBRIEF: Leo Guthart, Topspin Partners

A Harvard man through and through (BA physics 1958, MBA 1960, doctorate in business administration 1966), Leo Guthart held leading positions at several national corporations before launching private equity fund Topspin Partners in 2000 – just in time for 9/11. With its trademark think-before-you-leap mantra, Topspin survived the Great Recession to become a key player in Long Island’s burgeoning innovation economy, including several joint investments with regional booster Accelerate Long Island through the Long Island…


SetPoint Medical

Feinstein’s vagus research takes plenty of nerve

BY GREGORY ZELLER // What happens in vagus doesn’t actually stay there. Or at least that’s the theory behind electrical stimulation of the vagus nerve, a long cranial bundle that extends from the brain to the abdomen. Medical science is just scratching the surface of the therapeutic value of vagus stimulation, but new studies suggest it goes far beyond the treatment of certain forms of epilepsy and depression, two longstanding targets of vagus manipulation. Dr….


Cold Spring Harbor Laboratory's Technology Transfer Chief Teri Willey

The Debrief: Teri Willey, Cold Spring Harbor Lab

Venture capitalization veteran Teri Willey came to Cold Spring Harbor Laboratory 18 months ago on a mission: to turn the lab’s life-altering science into bona fide business. As co-founder of seed venture fund ARCH Development Partners, VP of Technology & Business Development at Mount Sinai Medical Center and past president of the Association of University Technology Managers, among other distinguished positions, the University of Idaho graduate (with an MBA from Indiana State) had already shepherded…